Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Jun. 30, 2012

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill [Table Text Block]

Changes in the carrying amount of goodwill, by reportable segment, were as follows:

	Consumer Healthcare			Nutritionals		Rx Pharma- ceuticals			API			Total
Balance as of June 26, 2010	$	118,987		$	331,744	$	72,725		$	88,011		$	611,467
Currency translation adjustment	7,322			—		8,906			10,350			26,578
Balance as of June 25, 2011	126,309			331,744		81,631			98,361			638,045
Business acquisitions	15,040			—		148,865			—			163,905
Currency translation adjustment	(2,439		)	—		(9,727		)	(12,027		)	(24,193		)
Balance as of June 30, 2012	$	138,910		$	331,744	$	220,769		$	86,334		$	777,757

Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]

Other intangible assets and related accumulated amortization consisted of the following:

	June 30, 2012				June 25, 2011
	Gross		Accumulated Amortization		Gross		Accumulated Amortization
Amortizable intangibles:
Developed product technology/formulation and product rights	$	542,094	$	140,489	$	328,461	$	101,494
Customer relationships	341,363		50,757		331,081		32,029
Distribution and license agreements	52,609		23,686		52,790		19,844
Non-compete agreements	7,804		3,778		6,391		2,431
Trademarks	4,797		704		5,378		730
Total	948,667		219,414		724,101		156,528
Non-amortizable intangibles:
In-process research and development	35,000		—		—		—
Trade names and trademarks	7,365		—		6,857		—
Total other intangible assets	$	991,032	$	219,414	$	730,958	$	156,528

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

The estimated amortization expense for each of the following five years is as follows:

Fiscal Year	Amount
2013	$	75,100
2014	75,000
2015	74,300
2016	72,200
2017	69,700